Author:
Pan Youwen,Yang Yafang,Wu Jiale,Zhou Haiteng,Yang Chao
Publisher
Springer Science and Business Media LLC
Reference88 articles.
1. Burt AD, Lackner C, Tiniakos DG. Diagnosis and Assessment of NAFLD: definitions and histopathological classification. Semin Liver Dis. 2015;35(3):207–20.
2. Parker HM, Johnson NA, Burdon CA, Cohn JS, O’Connor HT, George J. Omega-3 supplementation and non-alcoholic fatty liver disease: a systematic review and meta-analysis. J Hepatol. 2012;56(4):944–51.
3. Younossi Z, Anstee QM, Marietti M, Hardy T, Henry L, Eslam M, George J. Bugianesi EJNrG, hepatology: global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Gastroenterol Hepatol. 2018;15(1):11–20.
4. Wong MCS, Huang JLW, George J, Huang J, Leung C, Eslam M, Chan HLY, Ng SC. The changing epidemiology of liver diseases in the Asia-Pacific region. Nat Rev Gastroenterol Hepatol. 2019;16(1):57–73.
5. Hardy T, Oakley F, Anstee QM, Day CP. Nonalcoholic fatty liver disease: pathogenesis and disease spectrum. Annu Rev Pathol. 2016;11:451–96.